Wolverine Asset Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-41,319
Closed -$2.27M 2864
2022
Q2
$2.27M Buy
+41,319
New +$2.17M 0.02% 516

Other funds holding SRRA

Wolverine Asset Management's SRRA Position: Q3 2022 in Review

Wolverine Asset Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 41,319 shares — an estimated $2.27M sold.

Wolverine Asset Management first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $2.27M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Wolverine Asset Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Wolverine Asset Management sold 41,319 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $2.27M.
  • Wolverine Asset Management first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Wolverine Asset Management's Sierra Oncology, Inc. Common Stock position peaked at $2.27M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Wolverine Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.